A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.

By R. Sandler, S. Halabi, J. Baron, S. Budinger, E. Paskett, R. Keresztes, N. Petrelli, M. Pipas, D. Karp, Charles L. Loprinz and 2 more. New England Journal of Medicine, 2003

1,189 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Pharmacology, Psychiatry and Mental health

View Paper: https://www.semanticscholar.org/paper/e82d4a2f3759a997224ce29cf0bc6894216b5b3f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Hanchen Li
2. Xueli Fan
3. D. Simmons
4. J. Houghton
5. R. Botting
6. T. Hla

Citations in the corpus

• Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition (2004, background): “…COX-1 inhibitor, has recently been shown in three randomized placebo-controlled trials to be “moderately effective” in preventing the appearance of sporadic colorectal adenomas in patients with a history of these tumors (Baron et al., 2003; Benamouzig et al., 2003; Sandler et al., 2003).”
• The Role of COX-2 in Intestinal Inflammation and Colorectal Cancer (2009, neutral): “Furthermore, a randomized double-blind trial showed that NSAIDs have preventive effects on patients with previous polyps (Sandler et al., 2003; Bertagnolli et al., 2006).”